NSE filing, NSE: LIBAS. Summary written from the filing by ALFA Finder's alert engine.
Libas Consumer Products Ltd: key numbers
- Share price
- ₹11.50
- Market cap
- ₹30.30 Cr
- Revenue (annual)
- ₹78.08 Cr
- Net profit (annual)
- ₹0.21 Cr
- P/E (TTM)
- 15.9×Sector 49.8×
- Promoter holding
- 32.68%+0.75% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Libas Consumer Products Ltd
All →Libas Consumer Products Legal & Regulatory
Libas Consumer Products paid ₹2.20 Crore as full and final settlement of all claims by G S Majestic Developers. This closes the prior dispute.
- Value
- ₹2.20 Cr
Libas Consumer Products Business Update
Libas Consumer Products will participate in Bangalore Fashion Week on October 17, 2026 under its brand 'LIBAS'. The event aims to enhance the company's brand credibility.
Libas Consumer Products Capacity Expansion
Libas Consumer Products opened a new wholesale store at APMC market, Vashi, Navi Mumbai. The store deals in coconut, rock salt, pink salt, and other consumer products.
- new wholesale stores
- 1 stores
Libas Consumer Products Annual General Meeting
Libas Consumer Products Limited concluded its 22nd Annual General Meeting on September 30, 2026. Shareholders approved the annual financial statements and the re-appointment of Director Riyaz Ganji.
Libas Consumer Products Fund Raise
Libas Consumer Products filed an application with NSE for in-principle approval of a rights issue. No monetary value is stated in this filing.
Libas Consumer Products Fund Raise of ₹14.5 Cr
Libas Consumer Products' board approved a rights issue of up to ₹14.50 crore in equity shares. The board also appointed Brickwork Ratings as monitoring agency.
- Value
- ₹14.50 Cr
Other business update announcements
All →Durlax Top Surface Business Update
Durlax Top Surface disclosed a CPWD certificate confirming its Luxor products performed satisfactorily at kitchen platforms and vanity counters at the PM's Principal Secretary bungalow. The filing carries no monetary amount or contract award.
Alkem Laboratories Business Update
Alkem informed the exchange that US FDA completed inspection of its Mandva API facility with no Form 483 observations. The clean result confirms regulatory compliance.
GAIL (India) Business Update
GAIL revises Durgapur-Haldia and Dhamra-Haldia pipeline completion to March 2027 due to unavailability of hindrance-free fronts. No additional investment is required for either section.
Kirloskar Industries Business Update
Kirloskar Industries forwarded Q1 FY27 unaudited results of subsidiary KFIL to exchanges. The filing discloses revenue, profit, and key financial ratios for the September quarter.
OneSource Specialty Pharma Business Update
OneSource received a USFDA EIR with VAI classification for its Bengaluru SPD facility. This marks completion of the June 2026 inspection with no monetary penalty.
GP Eco Solutions India Business Update
GP Eco Solutions shared a factory showcase video of subsidiary Invergy India's first-phase manufacturing facility. The video highlights production capabilities, infrastructure, and product portfolio.